Samsung and Fitbit have also followed in Apple’s footsteps in the years since the release of the Series 4 by releasing their own smartwatches with ECG applications, and the Samsung Galaxy Watch 3 also offers blood pressure monitoring – although it needs to be calibrated first with a dedicated blood pressure monitor, and every four weeks thereafter. However, Apple has continued to improve the accuracy of its Apple Watch ECG, recently gaining FDA clearance for an updated version of the feature that can detect a category of the condition known as AFib with high heart rate.
#CLEAR SHAHID APP DATA FROM SAMSUNG SMART TRIAL#
An early 2020 clinical trial cast doubt on the Apple Watch’s ability to detect AFib with much accuracy, and experts have also stated that widespread screening for conditions such as AFib – especially among the younger age groups who are likely to purchase a smartwatch – may not be necessary or particularly useful. Since the launch of the Series 4, Apple Watches have also been able to take an echocardiogram (ECG) using an electrical heart sensor, and check for an irregular rhythm that could mean the wearer has atrial fibrillation (AFib), a heart condition that can lead to complications such as blood clots, stroke and other heart-related issues. In September 2020, the Apple Watch Series 6 launched with new blood oxygen measuring functionality, and Apple is reportedly embarking on a series of health studies with research institutes to learn more about how changes in blood oxygen levels can signal the presence of respiratory conditions such as asthma. While not originally designed as medical devices, smart watches are becoming increasingly powerful healthcare tools thanks to a range of applications and features that have been added to them by manufacturers like Apple, Google and Samsung.Īpple in particular has consistently demonstrated a commitment to turning the Apple Watch into a device that can monitor and assist with health.
0 kommentar(er)
